CallahanD., Setting Limits: Medical Goals in an Aging Society (New York: Simon and Shuster, 1987); CallahanD., What Kind of Life? The Limits of Medical Progress (New York: Simon and Shuster, 1990); and HiattH., “Protecting the Medical Commons: Who is Responsible?,”N. Engl. J. Med., 293 (1975): 235–41.
2.
See EngelhardtH.T.Jr., The Foundations of Bioethics 2nd Edition (New York: Oxford University Press, 1995): In press; also appearing as EngelhardtH.T.Jr., Los Fundamentos de la Bioéthica (Barcelona: Paidós Básica, 1995).
3.
LohrK.N.YordyK.HarrisonP.F., “Health Care Systems: Lessons from International Comparisons,”Health Affairs, 11, no. 4 (1992): 239–41.
4.
Society of Critical Care Medicine, “The Society of Critical Care Medicine Ethics Committee Consensus Statement on the Triage of Critically Ill Patients,”JAMA, 271 (1994): 1200–03; Council on Ethical and Judicial Affairs, American Medical Association, “Ethical Issues in Health Care Reform; The Provision of Adequate Care,”JAMA, 272 (1994): 1056–62; and WolfeS., “Health Care Reform and the Future of Physician Ethics,”Hastings Center Report, 24, no. 2 (1994): 28–41.
5.
MarmotM.G., “Health Inequalities Among British Civil Servants: The Whitehall II Study,”The Lancet, 337 (1991): 1387–93.
6.
Bioethics Committee, Union of American Hebrew Congregations, Allocation of Scarce Medical Resources. Program Guide VII (Cincinnati: Union of American Hebrew Congregations, 1994).
7.
CullenD.J.ChernowB., “Predicting Outcome in Critically Ill Patients,”Critical Care Medicine, 22 (1994): 1345–47.
8.
MurphyD.J.BarbourB., GUIDe (Guidelines for Intensive Care in Denver), A Community Effort to Define Futile and Inappropriate Care (Anaheim: New Horizons/Society of Critical Care Medicine, 1994): At 326–31; MurphyD.J., “Commentary: The Public and the Profession: Meeting at the Right Place,”Journal of Law, Medicine & Ethics, 22 (1994): 161–62; and BrodyBaruch, personal communication, Mar. 1995, concerning the Harris County, Texas, Draft Guidelines on Institutional Policies on the Determination of Medically Inappropriate Interventions.
9.
National Center for State Courts, Guidelines for State Court Decision Making in Life Sustaining Medical Treatment Cases (St. Paul: West, 1993); and In the Matter of Baby K, 16 F.3d 590 (4th Cir. 1994), cert. denied, 115 S. Ct. 91 (1994).
10.
HadornD., “Setting Health Care Priorities in Oregon: Cost Effectiveness Meets the Rule of Rescue,”JAMA, 265 (1991): 2218–25; and EddyD., “What Do We Do About the Costs?,”JAMA, 264 (1990): 1161–70.
11.
ReinhardtU.E., “Managed Competition in Health Care Reform: Just Another Dream or the Perfect Solution?,”Journal of Law, Medicine & Ethics, 22 (1994): At 117, 115 (original emphasis).
12.
ReinhardtU.E., “Turning Our Gaze from Bread and Circus Games,”Health Affairs, 14, no. 1 (1995): At 33.
13.
AnnasG.J.MillerF.H., “The Empire of Death: How Culture and Economics Affect Informed Consent in the U.S., the U.K., and Japan,”American Journal of Law & Medicine, XX (1994): At 357.
14.
Oregon Health Services Commission, Report to the Governor and Legislature, Prioritization of Health Services (Salem: State of Oregon, 1991).
15.
MorreimE.H., “Justice and Health Care Rationing: Lessons from Oregon,” in StrosbergM.A.WienerJ.M.BakerR., eds., Rationing America's Medical Care: The Oregon Plan and Beyond (Washington, D.C.: Brookings Institution Press, 1991): 159–84; and RosenbaumS., “Poor Women, Poor Children, Poor Policy,” in StrosbergM.A.WienerJ.M.BakerR., eds., Rationing America's Medical Care: The Oregon Plan and Beyond (Washington, D.C.: Brookings Institution Press, 1992): 91–106.
16.
KitzhaberJ., “The Oregon Health Plan: Creating Moral Authority in Public and Private Health Insurance,” delivered at the University of Kentucky Forum, Apr. 6, 1994. (Videotape transcripts available from the Dept. of Anesthesiology.)
17.
1993 Or. Basic Health Care Act, ch. 835. “Any health care provider or plan contracting to provide services to the eligible population under this Act shall not be subject to criminal prosecution, civil liability or professional disciplinary action for failing to provide a service which the legislative assembly has not funded or has eliminated from its funding pursuant to Section 8 of this Act” (id., ch. 835, § 10).
18.
1993 Or. Basic Health Care Act, ch. 838.
19.
1993 Or. Basic Health Care Act, ch. 381.
20.
AmundsenD.W., “The Physician's Obligation to Prolong Life: A Medical Duty Without Classical Roots,”Hastings Center Report, 8, no. 4 (1978): 23–30.
21.
EngelhardtH.T.Jr.RieM.A., “Morality for the Medical Industrial Complex: A Code of Ethics for the Mass Marketing of Health Care,”N. Engl. J. Med., 319 (1988): 1086–89; and EngelhardtH.T.Jr.RieM.A., “Selling Virtue: Ethics as a Profit Maximizing Strategy in Health Care Delivery,”Journal of Health and Social Policy, 4 (1992): 27–35.
22.
StarrP., The Social Transformation of American Medicine (New York: Basic Books, 1982).
23.
See Morreim, supra note 15; AngellM., “The Doctor as Double Agent,”Kennedy Institute of Ethics Journal, 3 (1993): 279–86; AbramsF.R., “The Doctor with Two Heads: The Patient versus the Costs,”N. Engl. J. Med., 328 (1993): 975–76; and FrankelJ.J., “Medical Malpractice Law and Health Care Cost Containment: Lessons for Reformers from the Clash of Cultures,”Yale Law Journal, 103 (1994): 1297–1331.
24.
It is easy to understand this impetus when you consider that approximately 72 percent of the annual national health expenditures are allocations for high-technology treatments for 10 percent of the population. See BerkL.MonheitA.C., “The Concentrations of Health Expenditures: An Update,”Health Affairs, 11, no. 4 (1992): 145–49.
25.
EnthovenA.C.SingerS.J., “Market Based Reform: What to Regulate and by Whom,”Health Affairs, 14, no. 1 (1995): 105–19.
26.
In California Nurses Association v. Alta Bates Medical Center, a nursing organization alleged that workforce reengineering by the hospital corporation created an environment of decreasing safety standards for patients. The defendant sought dismissal on grounds that a labor-management dispute was at issue. The court rejected this argument and remanded the issue of unethical business practices to a state court. See California Nurses Association v. Alta Bates Medical Center, No. C-94-03555CW (N.D. Cal. Mar. 25, 1995).
27.
DarlingH., “Market Reform: Large Corporations Lead the Way,”Health Affairs, 14, no. 1 (1995): 122–24.
28.
RapoportJ., “A Method of Assessing the Clinical Performance and Cost Effectiveness of Intensive Care Units,”Critical Care Medicine, 22 (1994): 1385–91; and RapoportJ., “Explaining Variability of Cost Using Severity of Illness Measures for ICU Patients,”Medical Care, 28 (1990): 338–48.
29.
ShabotM.M., “Quality Assurance and Utilization Assessment: The Major By Products of an ICU Clinical Information System,” in Proceeding of the XV Symposium on Computer Applications in Medicine (Bethesda: American Medical Informatics Association, 1992): 554–59.
30.
RogersM.C.SyndermanR.RogersE.L., “Cultural and Organizational Implications of Academic Managed Care Networks,”N. Engl. J. Med., 331 (1994): 1374–77.
31.
MacLeodG.K., “Health Care Financing Reform in New Zealand,”Health Affairs, 13, no. 4 (1994): 210–15; and StreatS.JudsonJ.A., “New Zealand,” in Cost Containment: A Multicultural Approach (Anaheim: New Horizons/Society of Critical Care Medicine, 1994): 392–403.
32.
ZimmermanJ.E., “Patient Selection for Intensive Care: A Comparison of New Zealand and United States Hospitals,”Critical Care Medicine, 16 (1988): 318–26; and GordonS.BaerE.D., “Fewer Nurses to Answer the Buzzer,”New York Times, Dec. 6, 1994, at A23.
33.
MillmanActuariesRobertson, Health Care Management Guidelines (Seattle: Millman and Robertson, 1994).
34.
See HolderA.R., “Funding Innovative Medical Treatment,”Albany Law Review, 57 (1994): 795–810; Fox v. Health Net of California, No. 219692 (Cal. Super. Ct. 1993); Goepel v. Mail Handlers Benefit Plan, 1993 WL 384498 (D.N.J. 1993); Barnett v. Kaiser Foundation Health Plan, Inc. _ F.3d _1994 WL 400819 (9th Cir. 1994); and Von Stetina v. Florida Medical Center, 2 Fla. Supp. 2d 55 (17th Cir. 1982), 436 So. 2d 1022 (1983), 10 Fla. L. Weekly 286 (Fla. May 24, 1985).
35.
RieM.A., “A Social Responsibility to Die? Freedom Aging and AIDS,”Journal of Clinical Anesthesia, 1 (1989): 222–27; and BattinM., Ethical Issues in Suicide (Englewood Cliffs: Prentice Hall, 1982).
36.
MeyerM.MureA., “Not My Health Care,”Newsweek, Jan. 10, 1994, at 36–38.
37.
LevinskyN.G., “The Organization of Medical Care: Lessons From the Medicare End Stage Renal Disease Program,”N. Engl. J. Med., 329 (1993): 1395–99.
38.
See supra note 21 and accompanying text.
39.
See Morreimsupra note 15. See also DanielsN., “Just Caring: Health Care Reform and Health Care Rationing,”Journal of Medicine and Philosophy, 19 (1994): 425–33; MarinerW.K., “Medical Technology Assessment—Intended For Whom?,”American Journal of Public Health, 83 (1993): 1525–26; HavighurstC., “Altering the Applicable Standard of Care,”Law and Contemporary Problems, 49 (1986): 265–76; HavighurstC., “The Changing Locus of Decision Making in the Health Care Sector,”Journal of Health Politics, Policy and Law, 11 (1986): 697–735; MorreimE.H., “Stratified Scarcity: Redefining the Standard of Care,”Law, Medicine & Health Care, 17 (1989): 356–67; HallM.A., “Informed Consent to Rationing Decisions,”Milbank Quarterly, 71 (1993): 645–68; AndersonG.F.HallM.A.SteinbergE.P., “Medical Technology Assessment and Practice Guidelines: Their Day in Court,”American Journal of Public Health, 83 (1993): 165–71; MorreimE.H., Balancing Act: The New Medical Ethics of Medicine's New Economics (Boston: Kluwer Academic, 1991); and MillerF.H., “Denial of Health Care and Informed Consent in English and American Law,”American Journal of Law & Medicine, XVIII (1992): 37–71.
40.
EngelhardtH.T.Jr.RieM.A., “Intensive Care Units, Scarce Resources and Conflicting Principles of Justice,”JAMA, 253 (1986): 1159–63.
41.
TeresD.LemeshowS., “Severity of Illness Modeling,” in RippeJ., ed., Intensive Care Medicine (Boston: Little Brown, 3rd ed., 1995): In press; KnausW.A., “The APACHE-III Prognostic Scoring System: Risk Prediction of Hospital Mortality for Critically III Hospitalized Adults,”Chest, 100 (1991): 1619–36; LemeshowS., “Mortality Probability Models (MPM-II) Based on an International Cohort of Intensive Care Patients,”JAMA, 270 (1993): 2478–86; LeGallJ.LemeshowS.SaulnierF., “A New Simplified Physiology Score (SAPS-II) Based on a European-North American Multicenter Study,”JAMA, 270 (1993): 2957–63; and BirnbaumM.L., “Cost Containment in Critical Care,” in RippeJ.M., eds., Intensive Care Medicine (Boston: Little Brown, 2nd ed., 1991): 1977–97.
42.
See Society of Critical Care Medicine, supra note 4.
43.
ShortellS.M.ReinhardtU.E., Improving Health Policy and Management: Nine Critical Research Issues for the 1990's (Ann Arbor: Health Administration Press, 1992).
44.
The figures for mortality and time in this paragraph are fictitious. Specific quantification of the variables would be negotiated. Negotiations would permit buyers and sellers to meet in a morally contentful insurance market place.
45.
See Morreim, supra note 15; and Morreim, supra note 39.
46.
See EngelhardtRie, supra note 40.
47.
Some readers will be concerned about a hospital's ability to guarantee care to a patient in a basic tier entitlement status when that patient could be displaced by another who had previously purchased an enhanced benefit to marginally beneficial care. The Oregonian ICU applies to actuarially valid health systems with a minimum of 50,000 covered lives. In these systems, patients would be moved if necessary, and sufficient beds within the system will guarantee that the entitlement of the basic tier will not be violated by patients in a higher entitlement tier. Properly executed, mesoallocatory ICU health policy protects the least well off members of society by assuring quality delivery of the basic minimum benefits.
48.
See TeresLemeshow, supra note 41.
49.
See EngelhardtRie, supra note 40.
50.
The SUPPORT project's definition of futility uses a mathematical definition of futility at the 1 percent survival rate. But such analysis itself is another articulation of the national health care ideology. Futility is a subjective value where consumers, providers, and the courts already disagree. The relevant question addressed by the Oregonian ICU is: What goals are worth pursuing with our collective health insurance funds, given the finite resources of the group and the infinite demand from the financially sheltered patient and the death-denying health professionals? See TenoJ.M., “Prognosis Based Futility Guidelines: Does Anyone Win?,”Journal of the American Geriatric Society, 42 (1994): 1202–07; and LynnJ.KnausW.A., “Background for SUPPORT,”Journal of Clinical Epidemiology, 43, Supp. (1990): 1S–4S.
51.
See supra note 50.
52.
AnnasG., “Informed Consent, Cancer and Truth in Prognosis,”N. Engl. J. Med., 330 (1994): 223–25.
53.
See supra note 21 and accompanying text.
54.
See Society of Critical Care Medicine, supra note 4.
55.
See supra note 9 and accompanying text.
56.
See Morreim, supra note 15; and Morreim, supra note 39.
57.
RieM.A.AckermanF.CallahanD.“Helga Wanglie's Ventilator,”Hastings Center Report, 21, no. 4 (1991): 23–35.
58.
ScitovskyA.A., “‘The High Cost of Dying’ Revisited,”Milbank Quarterly, 72 (1994): 561–91.
59.
WildesK.W., Critical Care and Critical Choices: Catholic Studies in Bioethics (Dordrecht: Kluwer Academic, 1995): In press; and Bioethics Committee, supra note 7.